Epidemiological support for genetic variability at hypothalamic-pituitary-adrenal axis and serotonergic system as risk factors for major depression

Neuropsychiatric Disease and Treatment

Volumn 11, Issue , 2015, Pages 2743-2754

  Ching López, Ana ^a   Cervilla, Jorge ^a,b   Rivera, Margarita ^a,b   Molina, Esther ^c   McKenney, Kathryn ^a   Ruiz Perez, Isabel ^b,d,e   Rodríguez Barranco, Miguel ^d   Gutiérrez, Blanca ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b Instituto de Investigación Biosanitaria   (Spain)

^c UNIVERSITY OF SEVILLE   (Spain)

^d ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^e CICIBERER de Epidemiología y S alud Pública CI BERES P   (Spain)

Author keywords

Genetic association analysis; HPA axis; Major depression; Serotonergic system

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; SEROTONIN 2A RECEPTOR;

ADULT; ARTICLE; CHROMOSOME 11; CHROMOSOME 13; CHROMOSOME 17; CONTROLLED STUDY; CRHR1 GENE; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DSM-IV; ENVIRONMENTAL FACTOR; FEMALE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HTR2A GENE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIFESTYLE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MIDDLE AGED; PSYCHOLOGICAL ASPECT; RISK FACTOR; SEROTONINERGIC SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; TPH1 GENE;

EID: 84945529031     PISSN: None     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S90369     Document Type: Article

References (60)

1. Demyttenaere K, Bruffaerts R, Posada-Villa J, et al. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA. 2004;291(21): 2581-2590.
2. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095-3105.
3. World Health Organization: The Global Burden of Disease: 2004 Update. Geneva: WHO Press; 2008:146.
4. Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry. 2000;157(10): 1552-1562.
5. Kendler KS, Gatz M, Gardner CO, Pedersen NL. A Swedish national twin study of lifetime major depression. Am J Psychiatry. 2006;163(1): 109-114.
6. Kendler KS, Gatz M, Gardner CO, Pedersen NL. Personality and major depression: a Swedish longitudinal, population-based twin study. Arch Gen Psychiatry. 2006;63(10):1113-1120.
7. Collins PY, Patel V, Joestl SS, et al. Grand challenges in global mental health. Nature. 2011;475(7354):27-30.
8. Flint J, Kendler KS. The genetics of major depression. Neuron. 2014; 81(3):484-503.
9. Cervilla J, Ruiz I, Rodríguez-Barranco M, et al. Study protocol and methods in the Andalusian epidemiological mental health study (PISMA-ep study). Rev Psiquiatr Salud Ment. 2015. in Press.
10. Ocaña-Riola R, Sánchez-Cantalejo C. Rurality index for small areas in Spain. Soc Indic Res. 2005;73(2):247-266.
11. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl. 20):22-33;quiz 34-57.
12. Sullivan PF, de Geus EJ, Willemsen G, et al. Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Mol Psychiatry. 2009;14:359-375.
13. Lewis CM, Ng MY, Butler AW, et al. Genome-wide association study of major recurrent depression in the UK population. Am J Psychiatry. 2010;167:949-957.
14. Muglia P, Tozzi F, Galwey NW, et al. Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts. Mol Psychiatry. 2010;15:589-601.
15. Rietschel M, Mattheisen M, Frank J, et al. Genome-wide association-, replication-, and neuroimaging study implicates HOMER1 in the etiology of major depression. Biol Psychiatry. 2010;68:578-585.
16. Kohli MA, Lucae S, Saemann PG, et al. The neuronal transporter gene SLC6A15 confers risk to major depression. Neuron. 2011;70: 252-265.
17. Shi J, Potash JB, Knowles JA, et al. Genome-wide association study of recurrent early-onset major depressive disorder. Mol Psychiatry. 2011;16: 193-201.
18. Shyn SI, Shi J, Kraft JB, et al. Novel loci for major depression identified by genome-wide association study of sequenced treatment alternatives to relieve depression and meta-analysis of three studies. Mol Psychiatry. 2011;16:202-215.
19. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559-575.
20. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet. 2004;74(4):765-769.
21. Bradley RG, Binder EB, Epstein MP, et al. Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Arch Gen Psychiatry. 2008;65(2):190-200.
22. Kranzler HR, Feinn R, Nelson EC, et al. A CRHR1 haplotype moderates the effect of adverse childhood experiences on lifetime risk of major depressive episode in African-American women. Am J Med Genet B Neuropsychiatr Genet. 2011;156b(8):960-968.
23. Nugent NR, Tyrka AR, Carpenter LL, Price LH. Gene-environment interactions: early life stress and risk for depressive and anxiety disorders. Psychopharmacology. 2011;214(1):175-196.
24. Polanczyk G, Caspi A, Williams B, et al. Protective effect of CRHR1 gene variants on the development of adult depression following childhood maltreatment: replication and extension. Arch Gen Psychiatry. 2009;66(9):978-985.
25. Maier R, Moser G, Chen G, Ripke S, Cross-disorder working group of the Psychiatric Genomics Consortium. Joint analysis of psychiatric disorder increases accuracy risk prediction for schizophrenia, bipolar disorder, and major depressive disorder. Am J Hum Genet. 2015;96: 283-294.
26. Anguelova M, Benkelfat C, Turecki G. A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders. Mol Psychiatry. 2003; 8(6):574-591.
27. López-León S, Janssens AC, González-Zuloeta Ladd AM, et al. Meta-analyses of genetic studies on major depressive disorder. Mol Psychiatry. 2008;13:772-785.
28. Kishi T, Tsunoka T, Ikeda M, et al. Serotonin 1A receptor gene and major depressive disorder: an association study and meta-analysis. Hum Genet. 2009;54:629-633.
29. Fukuo Y, Kishi T, Yoshimura R, et al. Serotonin 6 receptor gene and mood disorders: case-control study and meta-analysis. Neurosci Res. 2010;67: 250-255.
30. Pariante CM, Lightman SL. The HPA axis in major depression: classical theories and new developments. Trends Neurosci. 2008;31(9): 464-468.
31. Lopez JF, Chalmers DT, Little KY, Watson SJ. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol Psychiatry. 1998;43(8):547-573.
32. Kato M, Serretti A. Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol Psychiatry. 2010; 15(5):473-500.
33. Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Annu Rev Med. 2009;60:355-366.
34. Wang L, Erlandsen H, Haavik J, Knappskog PM, Stevens RC. Three-dimensional structure of human tryptophan hydroxylase and its implications for the biosynthesis of the neurotransmitters serotonin and melatonin. Biochemistry. 2002;41(42):12569-12574.
35. Andre K, Kampman O, Viikki M, et al. TPH1 A218C polymorphism and temperament in major depression. BMC Psychiatry. 2013;13:118.
36. Kim SW, Park SY, Hwang O. Up-regulation of tryptophan hydroxylase expression and serotonin synthesis by sertraline. Mol Pharmacol. 2002; 61(4):778-785.
37. Lai TJ, Wu CY, Tsai HW, Lin YM, Sun HS. Polymorphism screening and haplotype analysis of the tryptophan hydroxylase gene (TPH1) and association with bipolar affective disorder in Taiwan. BMC Med Genet. 2005;6:14.
38. Shi J, Badner JA, Hattori E, et al. Neurotransmission and bipolar disorder: a systematic family-based association study. Am J Med Genet B Neuropsychiatr Genet. 2008;147b(7):1270-1277.
39. Brent D, Melhem N, Ferrell R, et al. Association of FKBP5 polymorphisms with suicidal events in the Treatment of Resistant Depression in Adolescents (TORDIA) study. Am J Psychiatry. 2010;167(2):190-197.
40. Kwak SH, Park BL, Kim H, et al. Association of variations in TPH1 and HTR2B with gestational weight gain and measures of obesity. Obesity. 2012;20(1):233-238.
41. Opel N, Redlich R, Grotegerd D, et al. Obesity and major depression: body-mass index (BMI) is associated with a severe course of disease and specific neurostructural alterations. Psychoneuroendocrinology. 2015;51:219-226.
42. Luppino FS, de Wit LM, Bouvy PF, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010;67(3):220-229.
43. Hung CF, Rivera M, Craddock N, et al. Relationship between obesity and the risk of clinically significant depression: Mendelian randomisation study. Br J Psychiatry. 2014;205(1):24-28.
44. de Wit L, Luppino F, van Straten A, Penninx B, Zitman F, Cuijpers P. Depression and obesity: a meta-analysis of community-based studies. Psychiatry Res. 2010;178(2):230-235.
45. Belmaker RH, Agam G. Major depressive disorder. N Engl J Med. 2008; 358:55-68.
46. Norton N, Owen MJ. HTR2A: association and expression studies in neuropsychiatric genetics. Ann Med. 2005;37(2):121-129.
47. Bray NJ, Buckland PR, Hall H, Owen MJ, O’Donovan MC. The serotonin-2A receptor gene locus does not contain common polymorphism affecting mRNA levels in adult brain. Mol Psychiatry. 2004;9(1): 109-114.
48. Falkenberg VR, Gurbaxani BM, Unger ER, Rajeevan MS. Functional genomics of serotonin receptor 2A (HTR2A): interaction of polymorphism, methylation, expression and disease association. Neuromol Med. 2011;13(1):66-76.
49. Lanfumey L, Mongeau R, Cohen-Salmon C, Hamon M. Corticosteroid-serotonin interactions in the neurobiological mechanisms of stress-related disorders. Neurosci Biobehav Rev. 2008;32(6):1174-1184.
50. Porter RJ, Gallagher P, Watson S, Young AH. Corticosteroid-serotonin interactions in depression: a review of the human evidence. Psychopharmacology. 2004;173(12):1-17.
51. Zhao X, Sun L, Sun YH, et al. Association of HTR2A T102C and A-1438G polymorphisms with susceptibility to major depressive disorder: a meta-analysis. Neurol Sci. 2014;35(12):1857-1866.
52. Schatzberg AF, Keller J, Tennakoon L, et al. HPA axis genetic variation, cortisol and psychosis in major depression. Mol Psychiatry. 2014; 19(2):220-227.
53. Binder EB, Nemeroff CB. The CRF system, stress, depression and anxiety - insights from human genetic studies. Mol Psychiatry. 2010;15: 574-588.
54. Liu Z, Zhu F, Wang G, et al. Association study of corticotropin-releasing hormone receptor1 gene polymorphisms and antidepressant response in major depressive disorders. Neurosci Lett. 2007;414(2):155-158.
55. Ishitobi Y, Nakayama S, Yamaguchi K, et al. Association of CRHR1 and CRHR2 with major depressive disorder and panic disorder in a Japanese population. Am J Med Genet B Neuropsychiatr Genet. 2012;159(4): 429-436.
56. Rogers J, Raveendran M, Fawcett GL, et al. CRHR1 genotypes, neural circuits and the diathesis for anxiety and depression. Mol Psychiatry. 2013;18(6):700-707.
57. Licinio J, O’Kirwan F, Irizarry K, et al. Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans. Mol Psychiatry. 2004;9(12): 1075-1082.
58. Leonard BE, Myint A. The psychoneuroimmunology of depression. Hum Psychopharmacol. 2009;24(3):165-175.
59. Green AR, Sourkes TL, Young SN. Liver and brain tryptophan metabolism following hydrocortisone administration to rats and gerbils. Br J Pharmacol. 1975;53(2):287-292.
60. Patnala R, Clements J, Batra J. Candidate gene association studies: a comprehensive guide to useful in silico tools. BMC Genet. 2013;14:39.